NCT07093736View on ClinicalTrials.gov

A Study Comparing Immediate Treatment to Deferred Treatment With the Fisher Wallace (FW) Stimulator FW-200 Device for the Treatment of Self-reported Anxiety in First Responders

NACompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

July 6, 2021

Primary Completion Date

May 11, 2023

Study Completion Date

May 11, 2023

Conditions
Anxiety
Interventions
DEVICE

FW-200

Non-invasive, home-use neurostimulation device delivering transcranial fixed output, alternating current stimulation

Trial Locations (2)

30308

Florence Healthcare, Atlanta

98104

Seattle Police Department Wellness Unit, Seattle

Sponsors
All Listed Sponsors
collaborator

Advarra

INDUSTRY

collaborator

Florence Healthcare

UNKNOWN

lead

Fisher Wallace Laboratories

INDUSTRY

NCT07093736 - A Study Comparing Immediate Treatment to Deferred Treatment With the Fisher Wallace (FW) Stimulator FW-200 Device for the Treatment of Self-reported Anxiety in First Responders | Biotech Hunter | Biotech Hunter